Exclusive: Arena Bioworks, the buzzy research institute that launched with $500 million to support a decade of scientific R&D ...

A recent deep dive into the unraveling of Moderna by reporter Jason Mast is one of the most popular STAT stories of the year.

The new strategy shares themes with health secretary Robert F. Kennedy Jr.’s Make America Health Again agenda. He has called ...

In this edition of STAT's Health Tech newsletter: the latest on GLP-1 microdosing, AI for medical coding and more.

We’re also continuing to track the fallout from all the recent FDA controversies.

A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...

It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

Fewer pre-teens and adolescents are vaping nicotine these days than in previous years. But a study published yesterday in ...

Sobriety didn’t restore the old version of me; it allowed me to build a new one from the driftwood of the past,” ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...

Sarepta Therapeutics delivered a disastrous third-quarter earnings performance. A long-delayed confirmatory clinical trial of ...